ATE552256T1 - Neuartige form von tiotropium-bromid und herstellungsverfahren dafür - Google Patents
Neuartige form von tiotropium-bromid und herstellungsverfahren dafürInfo
- Publication number
- ATE552256T1 ATE552256T1 AT09010563T AT09010563T ATE552256T1 AT E552256 T1 ATE552256 T1 AT E552256T1 AT 09010563 T AT09010563 T AT 09010563T AT 09010563 T AT09010563 T AT 09010563T AT E552256 T1 ATE552256 T1 AT E552256T1
- Authority
- AT
- Austria
- Prior art keywords
- tiotropium bromide
- production
- novel form
- novel
- tiotropium
- Prior art date
Links
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 229960000257 tiotropium bromide Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75267205P | 2005-12-19 | 2005-12-19 | |
| US75453005P | 2005-12-27 | 2005-12-27 | |
| US76143706P | 2006-01-23 | 2006-01-23 | |
| US77405106P | 2006-02-15 | 2006-02-15 | |
| US78031006P | 2006-03-07 | 2006-03-07 | |
| US83218906P | 2006-07-20 | 2006-07-20 | |
| US85122306P | 2006-10-12 | 2006-10-12 | |
| US85274006P | 2006-10-18 | 2006-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE552256T1 true ATE552256T1 (de) | 2012-04-15 |
Family
ID=38115166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09010563T ATE552256T1 (de) | 2005-12-19 | 2006-12-19 | Neuartige form von tiotropium-bromid und herstellungsverfahren dafür |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US8163913B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1869035B2 (cg-RX-API-DMAC7.html) |
| JP (3) | JP5086267B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101395881B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102731494A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE552256T1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0608427A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2627729A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1869035T4 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2384486T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL187947A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007009988A (cg-RX-API-DMAC7.html) |
| PL (2) | PL2123650T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1869035E (cg-RX-API-DMAC7.html) |
| RS (1) | RS52663B2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200732340A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007075858A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101395881B1 (ko) * | 2005-12-19 | 2014-05-21 | 시코르, 인크. | 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법 |
| US9108962B2 (en) * | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| GB0716026D0 (en) * | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| PT2240477E (pt) * | 2008-01-10 | 2014-11-19 | Generics Uk Ltd | Um novo processo para a preparação de ésteres de escopina |
| EP2172190A1 (en) * | 2008-10-02 | 2010-04-07 | Laboratorios Liconsa, S.A. | Inhalable particles comprising tiotropium |
| KR101557633B1 (ko) * | 2008-11-04 | 2015-10-06 | 시플라 리미티드 | 낮은 결정화도를 갖는 티오트로피움 브로마이드 |
| BRPI0916047A2 (pt) * | 2008-11-04 | 2015-11-10 | Cipla Ltd | composição farmacêutica em aerossol, uso de uma composição farmacêutica em aerossol, método para tratamento de sintomas crônicos ou agudos severos, moderados ou leves, ou para tratamento profilático de um distúrbio respiratório, dispensador farmacêutico em aerossol, processo para fabricação de um dispensador farmacêutico em aerossol e processo para fabricação de um complexo de um agente ativo e um adjuvante |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
| US8697719B2 (en) * | 2009-08-07 | 2014-04-15 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| TR201111589A2 (tr) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür susuz kristal formu. |
| CZ304368B6 (cs) | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Směsný solvát tiotropium bromidu a způsob jeho přípravy |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| PT106142B (pt) | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
| EP2705838A1 (en) * | 2012-09-06 | 2014-03-12 | Xspray Microparticles Ab | Tiotropium preparations |
| EP2897955B1 (en) * | 2012-09-11 | 2019-11-06 | Bilgic, Mahmut | New tiotropium bromide crystalline form |
| UA115888C2 (uk) | 2012-11-05 | 2018-01-10 | Зентіва, К.С. | Стабілізація сольватів тіотропію |
| KR20150135328A (ko) | 2013-04-01 | 2015-12-02 | 풀매트릭스 인코퍼레이티드 | 티오트로피움 건조 분말 |
| EP2789611A1 (en) * | 2013-04-08 | 2014-10-15 | Cerbios-Pharma S.A. | A crystalline form of tiotropium bromide |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| RU2567539C1 (ru) * | 2015-02-04 | 2015-11-10 | Индивидуальный предприниматель Михайлов Олег Ростиславович | КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ |
| EP3414243A1 (en) | 2016-02-11 | 2018-12-19 | Sima Patent Ve Lisanslama Hizmetleri Ltd. STI | Crystalline form of tiotropium bromide anhydrate |
| US11365170B2 (en) | 2018-07-13 | 2022-06-21 | Kyowa Hakko Bio Co., Ltd. | Non-solvate crystal of eucomic acid and method for producing same |
| PT115583B (pt) | 2019-06-17 | 2022-05-02 | Hovione Farm S A | Processo contínuo para a preparação de medicamentos anticolinérgicos |
| EP4108230A1 (en) | 2021-06-24 | 2022-12-28 | Laboratoires SMB | New dry powder composition of tiotropium for inhalation |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610163A (en) | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US6736830B2 (en) | 2000-08-22 | 2004-05-18 | Deborah M. Roust | Baby pacifier |
| MXPA02005666A (es) * | 2000-10-12 | 2002-11-29 | Boehringer Ingelheim Pharma | Nuevos polvos para anhalacion que contienen tiotropio. |
| IL155335A0 (en) * | 2000-10-12 | 2003-11-23 | Boehringer Ingelheim Pharma | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| DE10064816A1 (de) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| US6608055B2 (en) | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| HRP20031066B1 (en) * | 2001-06-22 | 2011-10-31 | Boehringer Ingelheim Pharma Gmbh & Co.Kg. | Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| US6890291B2 (en) | 2001-06-25 | 2005-05-10 | Mission Medical, Inc. | Integrated automatic blood collection and processing unit |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| DE10212264A1 (de) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| PL375868A1 (en) | 2002-12-16 | 2005-12-12 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Tiotropium containing hfc solution formulations |
| UA83813C2 (ru) | 2002-12-20 | 2008-08-26 | Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг | Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола |
| DE10351196B4 (de) | 2003-10-28 | 2016-08-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verwendung einer anodisch mit Silizium bondbaren Glas-Keramik (LTCC) |
| EP2336126A1 (de) | 2003-11-03 | 2011-06-22 | Boehringer Ingelheim International GmbH | Tiotropiumsalze, Verfahren zu deren Herstellung und Arzneimittelformulierungen diese enthaltend |
| EP1682542B1 (de) | 2003-11-03 | 2009-12-30 | Boehringer Ingelheim International GmbH | Neues kristallines anhydrat mit anticholinerger wirksamkeit |
| EP2322522A1 (de) * | 2003-11-03 | 2011-05-18 | Boehringer Ingelheim International Gmbh | Neue Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| CN1271073C (zh) * | 2004-10-26 | 2006-08-23 | 江苏正大天晴药业股份有限公司 | 结晶性抗胆碱能药噻托溴铵晶体 |
| PL1881980T3 (pl) * | 2005-05-02 | 2013-01-31 | Boehringer Ingelheim Int | Nowe krystaliczne formy bromku tiotropium |
| EP1879888A2 (en) | 2005-05-02 | 2008-01-23 | Boehringer Ingelheim International GmbH | Crystalline forms of tiotropium bromide |
| CN101331128B (zh) * | 2005-12-19 | 2013-05-29 | 西科尔公司 | 噻托溴铵的形式及其制备方法 |
| KR101395881B1 (ko) * | 2005-12-19 | 2014-05-21 | 시코르, 인크. | 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법 |
| EP1923393A1 (en) | 2006-11-17 | 2008-05-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Crystalline form of tiotropium bromide and urea |
| EP2020403A1 (en) * | 2007-08-02 | 2009-02-04 | Esteve Quimica, S.A. | Process for the resolution of zopiclone and intermediate compounds |
| US8697719B2 (en) * | 2009-08-07 | 2014-04-15 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
-
2006
- 2006-12-19 KR KR1020077018777A patent/KR101395881B1/ko active Active
- 2006-12-19 JP JP2008538130A patent/JP5086267B2/ja active Active
- 2006-12-19 MX MX2007009988A patent/MX2007009988A/es unknown
- 2006-12-19 BR BRPI0608427-3A patent/BRPI0608427A2/pt not_active IP Right Cessation
- 2006-12-19 US US11/643,001 patent/US8163913B2/en active Active
- 2006-12-19 DK DK06847887.4T patent/DK1869035T4/en active
- 2006-12-19 AT AT09010563T patent/ATE552256T1/de active
- 2006-12-19 PL PL09010563T patent/PL2123650T3/pl unknown
- 2006-12-19 CA CA002627729A patent/CA2627729A1/en not_active Abandoned
- 2006-12-19 TW TW095147754A patent/TW200732340A/zh unknown
- 2006-12-19 PT PT68478874T patent/PT1869035E/pt unknown
- 2006-12-19 ES ES09010563T patent/ES2384486T3/es active Active
- 2006-12-19 CN CN201210232788XA patent/CN102731494A/zh active Pending
- 2006-12-19 EP EP06847887.4A patent/EP1869035B2/en active Active
- 2006-12-19 WO PCT/US2006/048734 patent/WO2007075858A2/en not_active Ceased
- 2006-12-19 PL PL06847887T patent/PL1869035T5/pl unknown
- 2006-12-19 EP EP09010563A patent/EP2123650B1/en active Active
- 2006-12-19 ES ES06847887.4T patent/ES2396978T5/es active Active
- 2006-12-19 RS RS20120583A patent/RS52663B2/sr unknown
-
2007
- 2007-12-06 IL IL187947A patent/IL187947A0/en unknown
-
2011
- 2011-12-28 US US13/339,042 patent/US8846926B2/en active Active
-
2012
- 2012-02-23 JP JP2012037796A patent/JP5567610B2/ja active Active
- 2012-03-05 US US13/412,586 patent/US20120165364A1/en not_active Abandoned
- 2012-06-04 JP JP2012127232A patent/JP2012176975A/ja active Pending
-
2013
- 2013-10-31 US US14/068,998 patent/US20140057935A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE552256T1 (de) | Neuartige form von tiotropium-bromid und herstellungsverfahren dafür | |
| DK1987152T3 (da) | Fremgangsmåde til fremstilling af optisk aktive chirale aminer | |
| HUS1200023I1 (hu) | Eljárás vakcinák elõállítására | |
| ATE444746T1 (de) | Eine herstellungsmethode von entacapon- enthaltenden granulaten für orale dosierformen | |
| ATE530519T1 (de) | Cyclobutylaminderivate | |
| ATE537168T1 (de) | Substituierte oxazolidinone und ihre verwendung | |
| WO2007015017A3 (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
| SE0401762D0 (sv) | Novel compounds | |
| CR8246A (es) | Forma cristalina gamma-d del clorhidrato de ivabradina, su procedimiento de preparacion y composiciones farmaceuticas que las contienen | |
| CY1112670T1 (el) | Παραγωγα του 5.6-bisaryl-2-πυριδιν-καρβοξαμιδιου, η παρασκευη τους και η εφαρμογη τους σε θεραπευτικη αγωγη ως ανταγωνιστες των υποδοχεων στην ουροτενσινη ii | |
| ATE482194T1 (de) | Indolonderivate, verfahren zu deren herstellung und deren anwendungen | |
| NO20074843L (no) | Nye salter av 6-heterocyklylsubstituerte heksahydrofenantridinderivater | |
| IL188069A0 (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| MA28635B1 (fr) | Methode de production de derives de 1, 4-diphenylazetidinone | |
| TW200640886A (en) | Crystalline forms of linezolid intermediate | |
| UA94080C2 (ru) | Ациклически-замещенные производные фуропиримидина и их применение для лечения сердечно-сосудистых заболеваний | |
| ATE437857T1 (de) | Neuartige pyridinylaminalkylen- und pyridinyloxalkylen-cyclopropanamine, herstellungsverfahren dafür und pharmazeutische zusammensetzungen damit | |
| EP1767628A4 (en) | PROCESS FOR THE PREPARATION OF DIPEPTIDES OR DIPEPTIDE DERIVATIVES | |
| RU2005120950A (ru) | Природный материал для изготовления керамических изделий | |
| BRPI0813111A2 (pt) | Derivados de furanose | |
| ATE538098T1 (de) | Verfahren zum herstellen von 5-fluor-1,3-dialkyl- 1h-pyrazol-4-carbonsäurechloriden | |
| ATE487714T1 (de) | Imino-oxazolidine und ihre verwendung als antikoagulantien | |
| FR2908997B1 (fr) | Nouvelles compositions therapeutiques et le procede de production des principes actifs | |
| ATE469962T1 (de) | Proanthocyanidin-tannin-zusammensetzung, herstellungsverfahren dafür und verwendung davon |